2006•Cochrane Database of Systematic ReviewsRequires access

Trastuzumab containing regimens for metastatic breast cancer

Lorenzo Moja, Anna Compagnoni, Cinzia Brambilla, Jessie McGowan, Munira Nurbhai, Vanna Pistotti

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: 1. To evaluate the efficacy of trastuzumab (a monoclonal antibody against HER2) alone or in combination with other drug therapy in women with metastatic breast cancer. 2. To evaluate the toxicity of trastuzumab alone or in combination with other drug therapy in women with metastatic breast cancer.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 8 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Trastuzumab, Metastatic breast cancer, Medicine, Oncology, Breast cancer, Internal medicine, Monoclonal antibody, Drug